Repligen (RGEN) EBIAT (2016 - 2025)
Historic EBIAT for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $14.9 million.
- Repligen's EBIAT rose 237996.94% to $14.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 12147.0%. This contributed to the annual value of -$25.5 million for FY2024, which is 17167.66% down from last year.
- Latest data reveals that Repligen reported EBIAT of $14.9 million as of Q3 2025, which was up 237996.94% from $14.9 million recorded in Q2 2025.
- Repligen's EBIAT's 5-year high stood at $49.9 million during Q2 2022, with a 5-year trough of -$33.9 million in Q4 2024.
- Moreover, its 5-year median value for EBIAT was $16.9 million (2023), whereas its average is $18.9 million.
- Its EBIAT has fluctuated over the past 5 years, first plummeted by 13375.81% in 2023, then surged by 237996.94% in 2025.
- Over the past 5 years, Repligen's EBIAT (Quarter) stood at $29.1 million in 2021, then surged by 67.4% to $48.7 million in 2022, then tumbled by 133.76% to -$16.4 million in 2023, then plummeted by 105.89% to -$33.9 million in 2024, then surged by 144.03% to $14.9 million in 2025.
- Its EBIAT was $14.9 million in Q3 2025, compared to $14.9 million in Q2 2025 and $5.8 million in Q1 2025.